In this Medilink Midlands webinar, the Office for Life Sciences, the Government’s specialist team covering the sector, are eager to hear the views of Life Sciences businesses on how they are being affected by Brexit and the end of the Transition Period.
In this session, the Office for Life Sciences will reflect on areas where Brexit has led to a change (such as the regulation of medicines and devices; the way the border operates; and research and international recruitment) and invite attendees to share how their business has been affected.
The insights gained from this webinar will be fed back to Government Ministers and inform future Government policy making in relation to the Life Sciences.
This is an interactive session, with plenty of opportunity for questions, limited presentations, as well as guidance on where to go for further information, support and advice.
Alex Mclaughlin, Head of International Trade and Medical Device Regulation, Office for Life Sciences
Alex is responsible for all of OLS’s work on International Trade and Medical Device Regulation, advising Ministers in the Business and Health Departments.
Prior to his current role, Alex was Senior Private Secretary to two Health Ministers, established the Department’s epidemic vaccines programme, and worked for the Chief Medical Officer.
Robert Reid, Head of Regulation & Engagement, Office for Life Sciences
For the past 3 years Dr Robert Reid has headed up the Office for Life Science’s Medicines Regulation and Business Engagement function in the Trade Regulation and Analysis Team. Prior to this role, Rob worked as the Group Leader for the Biometrology research group at the National Physical Laboratory